Adaptimmune Therapeutics shares owned by DLK Investment Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by DLK Investment Management
from 13F filings
Historical chart of DLK Investment Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by DLK Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by DLK Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $29k | 31k | 0.95 |
| 2024-06-30 | $30k | 31k | 0.97 |
| 2024-03-31 | $48k | 31k | 1.58 |
| 2023-12-31 | $24k | 31k | 0.79 |